PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Cyclopentolate hydrochloride - Iritis
PAD Profile : Cyclopentolate hydrochloride - Iritis
Keywords :
eye drops, minims
Brand Names Include :
Mydrilate
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment licensed hospital indications ( including Iritis and Uveitis)
Cyclopentolate eye drops will be considered to be RED on the traffic light system.
New patients should be initiated on cyclopentolate eye drops by their consultant ophthalmologist.
Associated BNF Codes
11. Eye
11.05.00. Mydriatics and cycloplegics